Head and Neck Cancers

Latest News

Image of a laptop with the words "FDA Food and Drug Adminstration" visible
Oncology Drugs Approved by the FDA in June

July 2nd 2025

Oncologic therapies approved in June included indications in genitourinary, lung, and hematologic, and head and neck cancers.

Graphic that resembles a stamp of approval reading "FDA Approved"
FDA Approves Perioperative Pembrolizumab in Head and Neck SCC

June 12th 2025

Anatomical graphic of the head and neck with organs visible
Adding Nivolumab to Chemo/RT Yields Higher DFS in Head/Neck Cancer

June 1st 2025

Graphic reading "FDA Approved" resembling a stamp of approval
Belzutifan Granted FDA Approval for Pheochromocytoma or Paraganglioma

May 14th 2025

Light blue line illustration of a person's nasal cavity on a dark blue background
Eftilagimod Alfa/Pembrolizumab May Improve OS in HNSCC With CPS < 1

May 5th 2025

Video Interviews
Podcasts
Latest CME Events & Activities

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

View More

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

View More

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

View More

GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer

View More

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

View More

More News